Histamine, a biogenic amine, can be formed in foods via decarbonizing reactions of histidine and can cause health problems in consumers. Thus, histamine levels in foods, especially fermented seafood, are strictly controlled during harvesting, preserving, processing, and delivery. In this study, fermented mackerel (Scomberomorus guttatus) was collected and used to identify histamine-degrading bacteria. Five strains of bacteria grown in histamine medium were isolated, of which two strains (HF1 and HF2) showed the highest biomass in the 50 ppm histamine-supplied medium. After culturing for 24 hrs, the bacteria showed the highest activities at pH 7.0 and 30°C, and the efficiency of histamine degradation catalyzed by HF1 and HF2 strains was 34% and 31%, respectively. Biochemical characteristics investigation and 16S-rRNA sequencing of the HF1 indicated that the bacterial strain HF1 belonged to Pseudomonas aeruginosa and was identified as Pseudomonas aeruginosa HF1.
This study investigates the phytochemical and pharmacological profiles of Crinum asiaticum L. var. anomalum Baker from Vietnam. Phytochemical screening identified diverse secondary metabolites, including polyphenols, flavonoids, and alkaloids. Gas chromatography–mass spectrometry analysis of the n-hexane fractions revealed 19 major compounds. While all extracts showed moderate antioxidant activity, the chloroform fraction exhibited superior antidiabetic potential via α-amylase inhibition (IC50 = 83.13 ± 6.67 µg/mL). Furthermore, at non-cytotoxic concentrations (3.13 to 50 µg/mL), this fraction effectively rescued mouse β-TC6 insulinoma cells from thapsigargin. In anti-inflammatory assays, the n-hexane fraction significantly suppressed nitric oxide production in RAW 264.7 macrophages (IC50 = 53.12 ± 1.63 µg/mL). Notably, the extracts displayed remarkable selective anticancer activity, particularly the chloroform fraction against HeLa cervical and HepG2/Huh-7 hepatoma cell lines. In silico ADMET and Lipinski’s Rule of Five analyses confirmed that the key bioactive constituents possess favorable pharmacokinetic profiles and drug-likeness. These findings demonstrate C. asiaticum L. var. anomalum Baker as a promising natural source for developing multitarget therapeutic agents against inflammation, diabetes, and cancer.